IQVIA Holdings Inc.
$175.62
▼
-0.04%
2026-04-22 10:12:13
www.iqvia.com
NYQ: IQV
Explore IQVIA Holdings Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$29.52 B
Current Price
$175.62
52W High / Low
$247.05 / $134.65
Stock P/E
22.46
Book Value
$38.34
Dividend Yield
—
ROCE
10.59%
ROE
21.44%
Face Value
—
EPS
$7.84
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
93,000
Beta
1.39
Debt / Equity
245.93
Current Ratio
0.75
Quick Ratio
0.75
Forward P/E
11.89
Price / Sales
1.74
Enterprise Value
$42.69 B
EV / EBITDA
14.53
EV / Revenue
2.62
Rating
Strong Buy
Target Price
$232.25
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Strong operating margin profile.
Cons
- Leverage is relatively high.
- Current ratio suggests tighter short-term liquidity.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Danaher Corporation | $189.21 | 37.67 | $133.79 B | 0.82% | 6.12% | 7.05% | $242.8 / $180.03 | $74.32 |
| 2. | Labcorp Holdings Inc. | $271.17 | 25.93 | $22.36 B | 1.07% | 9.74% | 10.51% | $293.72 / $209.38 | $104.86 |
| 3. | Check-Cap Ltd. | $1.9 | — | $13.56 M | — | 659.83% | -1.3% | $3.92 / $0.59 | $0.64 |
| 4. | Revvity, Inc. | $93.89 | 28.42 | $10.54 B | 0.3% | 3.29% | 3.22% | $118.3 / $81.36 | $64.57 |
| 5. | Mettler-Toledo International Inc. | $1,328.56 | 31.6 | $26.93 B | — | 44.48% | -1154.87% | $1,525.17 / $962.54 | $-1.16 |
| 6. | Agilent Technologies, Inc. | $122.3 | 26.99 | $34.7 B | 0.84% | 14.25% | 19.95% | $160.27 / $99.12 | $24.44 |
| 7. | ICON Public Limited Company | $114.42 | 15.51 | $8.76 B | — | 8.66% | 6.27% | $211 / $66.57 | $122.25 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 4.36 B | 4.1 B | 4.02 B | 3.83 B | 3.96 B |
| Operating Profit | 651 M | 573 M | 538 M | 525 M | 622 M |
| Net Profit | 514 M | 331 M | 266 M | 249 M | 437 M |
| EPS in Rs | 3.06 | 1.97 | 1.58 | 1.48 | 2.6 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 16.31 B | 15.4 B | 14.98 B | 14.41 B |
| Operating Profit | 2.29 B | 2.27 B | 2.06 B | 1.83 B |
| Net Profit | 1.36 B | 1.37 B | 1.36 B | 1.09 B |
| EPS in Rs | 8.1 | 8.18 | 8.09 | 6.5 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 29.94 B | 26.9 B | 26.68 B | 25.34 B |
| Total Liabilities | 23.31 B | 20.83 B | 20.57 B | 19.57 B |
| Equity | 6.5 B | 6.07 B | 6.11 B | 5.76 B |
| Current Assets | 6.25 B | 5.83 B | 5.6 B | 4.98 B |
| Current Liabilities | 8.34 B | 6.96 B | 6.49 B | 5.58 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 2.65 B | 2.72 B | 2.15 B | 2.26 B |
| Investing CF | -2.31 B | -1.44 B | -1.6 B | -2.01 B |
| Financing CF | -150 M | -878 M | -382 M | -329 M |
| Free CF | 2.05 B | 2.11 B | 1.5 B | 1.59 B |
| Capex | -603 M | -602 M | -649 M | -674 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 2.81% | 3.98% | — | — |
| Earnings Growth % | 1.1% | 24.47% | — | — |
| Profit Margin % | 8.91% | 9.06% | 7.57% | — |
| Operating Margin % | 14.73% | 13.75% | 12.68% | — |
| Gross Margin % | 34.89% | 34.96% | 34.89% | — |
| EBITDA Margin % | 22.41% | 21.73% | 20.19% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.